Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
53,73 USD | -3,45% | -4,33% | -14,17% |
18/04 | CRISPR THERAPEUTICS AG : Citigroup ontvangt een koopadvies | ZM |
17/04 | Insider bij Crispr Therapeutics verkocht aandelen ter waarde van $1.173.232, volgens een recent SEC-document | MT |
Vakgebied
Aantal werknemers: 407
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Collaboration
99,7
%
| 0 | 36,4 % | 370 | 99,7 % | +84.762,39% |
Grant
0,3
%
| 1 | 63,6 % | 1 | 0,3 % | +58,27% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Switzerland and United States
100,0
%
| 1 | 100,0 % | 371 | 100,0 % | +30.885,48% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Samarth Kulkarni
CEO | Chief Executive Officer | 45 | 01-08-15 |
Raju Prasad
DFI | Director of Finance/CFO | 40 | 14-03-23 |
Stephen Kennedy
CTO | Chief Tech/Sci/R&D Officer | 67 | 01-10-19 |
Jonathan Terrett
CTO | Chief Tech/Sci/R&D Officer | - | 28-02-17 |
Susan Kim
IRC | Investor Relations Contact | - | - |
Alex Harding
PRN | Corporate Officer/Principal | - | 05-01-23 |
Human Resources Officer | - | 01-08-16 | |
Jim Kasinger
LAW | General Counsel | 52 | 01-05-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Doug Treco Treco
BRD | Director/Board Member | 66 | 11-06-20 |
Simeon George
BRD | Director/Board Member | 46 | 29-04-15 |
Ali Behbahani
BRD | Director/Board Member | 47 | 01-04-15 |
Maria Fardis
BRD | Director/Board Member | 56 | 09-06-22 |
Katherine High
BRD | Director/Board Member | 72 | 11-06-19 |
John Greene
BRD | Director/Board Member | 58 | 11-06-19 |
Samarth Kulkarni
CEO | Chief Executive Officer | 45 | 01-08-15 |
Director/Board Member | 61 | 10-06-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 85 053 407 | 83 305 141 ( 97,94 %) | 170 316 ( 0,2002 %) | 97,94 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-14,17% | 4,56 mld. | |
+1,12% | 42,59 mld. | |
+6,77% | 40,65 mld. | |
+45,26% | 40,57 mld. | |
-11,96% | 26,77 mld. | |
+6,01% | 24,81 mld. | |
-24,92% | 18,17 mld. | |
-3,63% | 11,7 mld. | |
+27,16% | 12,05 mld. | |
+7,30% | 11,1 mld. |
- Beurs
- Aandelen
- Koers CRSP
- Onderneming CRISPR Therapeutics AG